Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations.

Directed acyclic graphs causal diagrams causal inference confounding covariate adjustment graphical model theory observational studies reporting practices

Journal

International journal of epidemiology
ISSN: 1464-3685
Titre abrégé: Int J Epidemiol
Pays: England
ID NLM: 7802871

Informations de publication

Date de publication:
17 05 2021
Historique:
accepted: 12 10 2020
pubmed: 18 12 2020
medline: 8 7 2021
entrez: 17 12 2020
Statut: ppublish

Résumé

Directed acyclic graphs (DAGs) are an increasingly popular approach for identifying confounding variables that require conditioning when estimating causal effects. This review examined the use of DAGs in applied health research to inform recommendations for improving their transparency and utility in future research. Original health research articles published during 1999-2017 mentioning 'directed acyclic graphs' (or similar) or citing DAGitty were identified from Scopus, Web of Science, Medline and Embase. Data were extracted on the reporting of: estimands, DAGs and adjustment sets, alongside the characteristics of each article's largest DAG. A total of 234 articles were identified that reported using DAGs. A fifth (n = 48, 21%) reported their target estimand(s) and half (n = 115, 48%) reported the adjustment set(s) implied by their DAG(s). Two-thirds of the articles (n = 144, 62%) made at least one DAG available. DAGs varied in size but averaged 12 nodes [interquartile range (IQR): 9-16, range: 3-28] and 29 arcs (IQR: 19-42, range: 3-99). The median saturation (i.e. percentage of total possible arcs) was 46% (IQR: 31-67, range: 12-100). 37% (n = 53) of the DAGs included unobserved variables, 17% (n = 25) included 'super-nodes' (i.e. nodes containing more than one variable) and 34% (n = 49) were visually arranged so that the constituent arcs flowed in the same direction (e.g. top-to-bottom). There is substantial variation in the use and reporting of DAGs in applied health research. Although this partly reflects their flexibility, it also highlights some potential areas for improvement. This review hence offers several recommendations to improve the reporting and use of DAGs in future research.

Sections du résumé

BACKGROUND
Directed acyclic graphs (DAGs) are an increasingly popular approach for identifying confounding variables that require conditioning when estimating causal effects. This review examined the use of DAGs in applied health research to inform recommendations for improving their transparency and utility in future research.
METHODS
Original health research articles published during 1999-2017 mentioning 'directed acyclic graphs' (or similar) or citing DAGitty were identified from Scopus, Web of Science, Medline and Embase. Data were extracted on the reporting of: estimands, DAGs and adjustment sets, alongside the characteristics of each article's largest DAG.
RESULTS
A total of 234 articles were identified that reported using DAGs. A fifth (n = 48, 21%) reported their target estimand(s) and half (n = 115, 48%) reported the adjustment set(s) implied by their DAG(s). Two-thirds of the articles (n = 144, 62%) made at least one DAG available. DAGs varied in size but averaged 12 nodes [interquartile range (IQR): 9-16, range: 3-28] and 29 arcs (IQR: 19-42, range: 3-99). The median saturation (i.e. percentage of total possible arcs) was 46% (IQR: 31-67, range: 12-100). 37% (n = 53) of the DAGs included unobserved variables, 17% (n = 25) included 'super-nodes' (i.e. nodes containing more than one variable) and 34% (n = 49) were visually arranged so that the constituent arcs flowed in the same direction (e.g. top-to-bottom).
CONCLUSION
There is substantial variation in the use and reporting of DAGs in applied health research. Although this partly reflects their flexibility, it also highlights some potential areas for improvement. This review hence offers several recommendations to improve the reporting and use of DAGs in future research.

Identifiants

pubmed: 33330936
pii: 6012812
doi: 10.1093/ije/dyaa213
pmc: PMC8128477
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

620-632

Subventions

Organisme : Medical Research Council
ID : MR/K501402/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the International Epidemiological Association.

Références

Eur J Epidemiol. 2019 Mar;34(3):211-219
pubmed: 30840181
Environ Health. 2017 Oct 23;16(1):110
pubmed: 29078795
Epidemiology. 1999 Jan;10(1):37-48
pubmed: 9888278
Obesity (Silver Spring). 2017 Aug;25(8):1451-1459
pubmed: 28660652
Epidemiology. 2011 Sep;22(5):745
pubmed: 21811114
Int J Epidemiol. 2020 Feb 1;49(1):322-329
pubmed: 31325312
Int J Epidemiol. 2016 Dec 1;45(6):1887-1894
pubmed: 28089956
Am J Public Health. 2018 May;108(5):616-619
pubmed: 29565659
Ann Stat. 2013 Feb;41(1):196-220
pubmed: 25544784
Environ Res. 2013 Oct;126:91-7
pubmed: 23890968
Int J Epidemiol. 2016 Dec 1;45(6):1787-1808
pubmed: 27694566
Am J Epidemiol. 2013 Feb 15;177(4):292-8
pubmed: 23371353
Epidemiology. 2010 Jan;21(1):159
pubmed: 20010223
Arthritis Rheumatol. 2016 May;68(5):1156-64
pubmed: 26714126
BJOG. 2019 Jul;126(8):973-982
pubmed: 30891907
Int J Epidemiol. 2021 Jan 23;49(6):2058-2064
pubmed: 31298274
PLoS One. 2015 Jun 04;10(6):e0128933
pubmed: 26042802
Int J Epidemiol. 2021 Jan 23;49(6):2074-2082
pubmed: 32380551
BMC Med Res Methodol. 2008 Oct 30;8:70
pubmed: 18973665
Int J Colorectal Dis. 2016 Mar;31(3):579-85
pubmed: 26670673
Environ Health. 2017 Nov 21;16(1):127
pubmed: 29162109
Int J Epidemiol. 2016 Dec 1;45(6):1776-1786
pubmed: 26800751
Biom J. 2018 May;60(3):431-449
pubmed: 29292533
J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):87-93
pubmed: 26334742
Soc Sci Med. 2018 Aug;210:2-21
pubmed: 29331519
Epidemiology. 2010 Jul;21(4):586-7
pubmed: 20539116

Auteurs

Peter W G Tennant (PWG)

Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
Faculty of Medicine and Health, University of Leeds, Leeds, UK.
Alan Turing Institute, British Library, London, UK.

Eleanor J Murray (EJ)

Department of Epidemiology, School of Public Health, Boston University, Boston, MA, USA.

Kellyn F Arnold (KF)

Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
Faculty of Medicine and Health, University of Leeds, Leeds, UK.

Laurie Berrie (L)

Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
School of Geography, University of Leeds, Leeds, UK.
School of GeoSciences, University of Edinburgh, Edinburgh, UK.

Matthew P Fox (MP)

Department of Epidemiology, School of Public Health, Boston University, Boston, MA, USA.
Department of Global Health, Boston University, Boston, MA, USA.

Sarah C Gadd (SC)

Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
School of Geography, University of Leeds, Leeds, UK.

Wendy J Harrison (WJ)

Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
Faculty of Medicine and Health, University of Leeds, Leeds, UK.

Claire Keeble (C)

Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.

Lynsie R Ranker (LR)

Department of Epidemiology, School of Public Health, Boston University, Boston, MA, USA.

Johannes Textor (J)

Department of Tumour Immunology, Radboud University Medical Center, Nijmegen, The Netherlands.

Georgia D Tomova (GD)

Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
Faculty of Medicine and Health, University of Leeds, Leeds, UK.
Alan Turing Institute, British Library, London, UK.

Mark S Gilthorpe (MS)

Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
Faculty of Medicine and Health, University of Leeds, Leeds, UK.
Alan Turing Institute, British Library, London, UK.

George T H Ellison (GTH)

Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
Faculty of Medicine and Health, University of Leeds, Leeds, UK.
Centre for Data Innovation, Faculty of Science and Technology, University of Central Lancashire, Preston, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH